Cargando…
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
Inappropriate activation of epidermal growth factor receptor (EGFR) plays a causal role in many cancers including colon cancer. The activation of EGFR by phosphorylation is balanced by receptor kinase and protein tyrosine phosphatase activities. However, the mechanisms of negative EGFR regulation by...
Autores principales: | Asbagh, Layka Abbasi, Vazquez, Iria, Vecchione, Loredana, Budinska, Eva, De Vriendt, Veerle, Baietti, Maria Francesca, Steklov, Mikhail, Jacobs, Bart, Hoe, Nicholas, Singh, Sharat, Imjeti, Naga-Sailaja, Zimmermann, Pascale, Sablina, Anna, Tejpar, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259406/ https://www.ncbi.nlm.nih.gov/pubmed/25301722 |
Ejemplares similares
-
OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination
por: Baietti, Maria Francesca, et al.
Publicado: (2016) -
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells
por: Bosch-Vilaró, Albert, et al.
Publicado: (2016) -
Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2016) -
Syntenin mediates SRC function in exosomal cell-to-cell communication
por: Imjeti, Naga Sailaja, et al.
Publicado: (2017) -
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
por: Zhang, Wenjie, et al.
Publicado: (2015)